Biogen, one of the largest biotechs in the world, said the decision to stop the study was not based on safety concerns.
Biotech company shares plummet after ending potentially groundbreaking Alzheimer's drug trial
México Noticias Noticias
The company said the decision to end the trial was not based on safety concerns